Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NDAC meeting on calendar

This article was originally published in The Tan Sheet

Executive Summary

FDA tentatively schedules a joint meeting of the Nonprescription Drug Advisory Committee and the Drug Safety and Risk Management Advisory Committee Sept. 14, the agency's Web site says. If the meeting is scheduled, the subject will not be known until FDA posts a Federal Register notice or updates meeting materials on its site. NDAC last met in June 2009, also with DSRM and the Life Support Drugs committee, to discuss acetaminophen (1"The Tan Sheet" Jan. 4, 2010, In Brief)

Related Content

FDA lays out 2010 advisory committee slate





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts